Literature DB >> 33890447

The analysis of pleural complications of COVID-19 pneumonia

Merve Şatır Türk1, Irmak Akarsu1, Ismail Tombul1, Aykut Kankoç1, Nur Dilvin Özkan1, Elgun Valiyev1, Muhammet Sayan1, Ali Çelik1, Ismail Cüneyt Kurul1, Olgun Kadir Arıbaş1, Abdullah Irfan Taştepe1.   

Abstract

Background/aim: As the number of case reports related to the new type of coronavirus (COVID-19) increases, knowledge of and experience with the virus and its complications also increase. Pleural complications are one relevant issue. We aimed in this study to analyze pleural complications, such as pneumothorax, pneumomediastinum, and empyema, in patients hospitalized with the diagnosis of COVID-19 pneumonia. Materials and methods: The files of patients who have pleural complications of COVID-19 pneumonia and were consulted about thoracic surgery between March 2020 and December 2020 were retrospectively reviewed. The data of the patients were analyzed according to age, sex, length of stay, treatment method for pleural complications, mortality, severity of COVID-19 pneumonia, tube thoracostomy duration, and presence of a mechanical ventilator.
Results: A total of 31 patients fulfilling the inclusion criteria were included in the study. There were 11 female (35.5%) and 20 male (65.5%) patients. The most common complication was pneumothorax in 20 patients (65%). The median duration of hospitalization was 22 days and the mortality rate was 71%. Mortality was significantly higher in patients on mechanical ventilation (p = 0.04).
Conclusion: The mortality rate is very high in patients with pleural complications of COVID-19 pneumonia. Pneumothorax is a fatal complication in critically ill patients with COVID-19 pneumonia.

Entities:  

Keywords:  Covid-19; Pneumothorax; empyema; pneumomediastinum

Mesh:

Year:  2021        PMID: 33890447     DOI: 10.3906/sag-2012-268

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  1 in total

1.  Pyopneumothorax induced by rupture of pneumatocele after COVID-19: A case report.

Authors:  Hanako Koda; Ryusuke Sumiya; Hideki Miyazaki; Satoshi Nagasaka
Journal:  Asian J Surg       Date:  2022-08-12       Impact factor: 2.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.